ANIK – Anika Therapeutics Inc.

ANIK — Price & Forward EBITDA

Forward EBITDA (M)

Float Short %

5.53

Margin Of Safety %

-35

Put/Call OI Ratio

0.05

EPS Next Q Diff

-0.06

EPS Last/This Y

0.14

EPS This/Next Y

0.15

Price

14.93

Target Price

Analyst Recom

Performance Q

57.55

Upside

-278.3%

Beta

0.28

Ticker: ANIK

16 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-03-09	ANIK	14.96	0.15	0.00	624
2026-03-10	ANIK	14.46	0.15	0.08	647
2026-03-11	ANIK	14.36	0.15	0.08	647
2026-03-12	ANIK	14.31	0.14	0.00	652
2026-03-13	ANIK	14.3	0.14	0.00	652
2026-03-17	ANIK	14.5	0.15	0.00	641
2026-03-18	ANIK	14.13	0.15	0.00	641
2026-03-20	ANIK	13.85	0.16	999.99	663
2026-03-25	ANIK	14.54	0.05	0.00	405
2026-03-26	ANIK	14.77	0.05	0.00	405
2026-03-27	ANIK	14.3	0.05	0.00	405
2026-03-30	ANIK	14.12	0.05	0.00	405
2026-03-31	ANIK	14.46	0.05	0.00	405
2026-04-01	ANIK	14.97	0.05	0.00	405
2026-04-06	ANIK	14.77	N/A	N/A	0
2026-04-07	ANIK	14.94	0.05	0.00	406
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

16 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-03-09	ANIK	14.98	100.0	-	0.25
2026-03-10	ANIK	14.44	100.0	-	0.25
2026-03-11	ANIK	14.38	100.0	-	0.25
2026-03-12	ANIK	14.29	100.0	-	0.25
2026-03-13	ANIK	14.23	100.0	-	0.25
2026-03-17	ANIK	14.52	100.0	-	0.25
2026-03-18	ANIK	14.11	100.0	-	0.25
2026-03-19	ANIK	14.20	100.0	-	0.25
2026-03-20	ANIK	13.85	100.0	-	0.25
2026-03-23	ANIK	14.27	100.0	-	0.25
2026-03-24	ANIK	14.28	100.0	-	0.25
2026-03-25	ANIK	14.56	100.0	-	0.25
2026-03-26	ANIK	14.76	100.0	-	0.25
2026-03-27	ANIK	14.30	100.0	-	0.25
2026-03-30	ANIK	14.13	100.0	-	0.25
2026-03-31	ANIK	14.47	100.0	-	0.25
2026-04-01	ANIK	14.98	100.0	-	0.25
2026-04-02	ANIK	14.83	100.0	-	0.25
2026-04-06	ANIK	14.77	100.0	-	0.25
2026-04-07	ANIK	14.93	100.0	-	0.25
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

19 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-03-09	ANIK	0.00	0.22	5.94
2026-03-10	ANIK	0.00	0.22	5.94
2026-03-11	ANIK	0.00	0.22	5.69
2026-03-12	ANIK	0.00	0.22	5.69
2026-03-13	ANIK	0.00	0.22	5.69
2026-03-18	ANIK	0.00	0.62	5.69
2026-03-19	ANIK	0.00	0.62	5.69
2026-03-20	ANIK	0.00	0.62	5.69
2026-03-23	ANIK	0.00	0.62	5.69
2026-03-24	ANIK	0.00	0.62	5.69
2026-03-25	ANIK	0.00	0.62	5.53
2026-03-26	ANIK	0.00	0.62	5.53
2026-03-27	ANIK	0.00	0.62	5.53
2026-03-30	ANIK	0.00	0.53	5.53
2026-03-31	ANIK	0.00	0.53	5.53
2026-04-01	ANIK	0.00	0.53	5.53
2026-04-02	ANIK	0.00	0.53	5.53
2026-04-06	ANIK	0.00	0.63	5.53
2026-04-07	ANIK	0.00	0.63	5.53
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

19 items 1 of 1

Last Quarter Act. EPS

0.13

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

0.07

Insider Transactions

Institutional Transactions

0.63

Beta

0.28

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

9.77

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

69.1

Max Drawdown 5-Year %

-83.2

Target Price

P/E

Forward P/E

66.31

PEG

0.98

P/S

1.77

P/B

1.44

P/Free Cash Flow

45.86

EPS

-0.76

Average EPS Est. Cur. Y

0.25

EPS Next Y. (Est.)

0.4

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-9.64

Relative Volume

0.71

Return on Equity vs Sector %

-35

Return on Equity vs Industry %

-14.9

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.01

EBIT Estimation

◆ ANIK Healthcare

$14.92

📉

Swing / Pullback

Buy the dip on strong trends

WEAK

Trend

8/20

Pullback

8/25

Volume

9/15

Valuation

11/20

TP/AR

2/10

Options

7/10

RSI

64.8

Range 1M

79.1%

Sup Dist

2.1%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

9/25

Growth

19/30

Estimates

1/20

Inst/Vol

7/15

Options

8/10

EPS Yr

-104.6%

EPS NY

4600%

52W%

95.8%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🔴 SELL -10.7% upside

Quality

6/30

Valuation

5/30

Growth

13/25

Stability

9/10

LT Trend

3/5

Upside

-10.7%

Quality

MoS

-35%

Anika Therapeutics Inc.

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Employees: 235

Anika Therapeutics, Inc., a joint preservation company, focuses on early intervention orthopedics in the United States, Europe, and internationally. The company offers osteoarthritis (OA) pain management products and services, such as Monovisc and Orthovisc, which are single- and multi-injection, HA viscosupplement products indicated for pain relief from OA conditions, as well as Cingal, a non-opioid, single-injection OA pain management product; regenerative solutions, including an HA-based scaffold with bone and tendon fixation components and arthroscopic delivery instruments; Hyalofast, a resorbable scaffold used for single stage cartilage regeneration; and Tactoset injectable bone substitute, an HA-enhanced injectable bone repair therapy designed to treat insufficiency fractures and augment hardware fixation. It also provides Integrity, an HA-based scaffold with bone and tendon fixation components and arthroscopic delivery instruments; non-orthopedic products, including Hyvisc, a high molecular weight injectable HA veterinary product for the treatment of joint dysfunction in horses due to non-infectious synovitis associated with equine OA; Hyalobarrier, an anti-adhesion barrier indicated for use after abdominal-pelvic surgeries; and ophthalmic products; and Anikavisc and Nuvisc high molecular weight HA products. The company was founded in 1983 and is headquartered in Bedford, Massachusetts.

ANIK

Latest News

—

Caricamento notizie per ANIK…

stock quote shares ANIK – Anika Therapeutics Inc. Stock Price stock today

news today ANIK – Anika Therapeutics Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch ANIK – Anika Therapeutics Inc. yahoo finance google finance

stock history ANIK – Anika Therapeutics Inc. invest stock market

stock prices ANIK premarket after hours

ticker ANIK fair value insiders trading

ANIK – Anika Therapeutics Inc.

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: ANIK

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y